Michael R Blackburn Selected Research

2,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylate

7/2004

A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael R Blackburn Research Topics

Disease

31	Inflammation (Inflammations) 11/2019 - 02/2002
29	Fibrosis (Cirrhosis) 01/2020 - 08/2003
23	Lung Diseases (Lung Disease) 01/2019 - 02/2003
21	Pneumonia (Pneumonitis) 09/2017 - 02/2002
17	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 08/2005
13	Asthma (Bronchial Asthma) 12/2020 - 02/2002
13	Lung Injury 01/2019 - 01/2005
11	Hypoxia (Hypoxemia) 07/2018 - 01/2012
10	Chronic Obstructive Pulmonary Disease (COPD) 12/2013 - 07/2004
7	Acute Lung Injury 01/2021 - 06/2010
6	Neoplasms (Cancer) 01/2019 - 01/2016
6	Severe combined immunodeficiency due to adenosine deaminase deficiency 03/2015 - 08/2002
5	Priapism 06/2014 - 04/2008
4	Respiratory Hypersensitivity 12/2020 - 06/2007
4	Airway Remodeling 12/2020 - 01/2006
4	Idiopathic Pulmonary Fibrosis 10/2019 - 02/2010
4	Pulmonary Hypertension 01/2019 - 06/2012
4	Infections 09/2017 - 10/2007
4	Pulmonary Edema 08/2015 - 06/2010
4	Hypertension (High Blood Pressure) 02/2015 - 01/2012
4	Ischemia 11/2013 - 02/2005
3	Chronic Disease (Chronic Diseases) 10/2019 - 01/2011
3	Emphysema 01/2019 - 05/2006
3	Disease Progression 01/2018 - 02/2016
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018 - 01/2011
3	Airway Obstruction (Choking) 09/2014 - 11/2006
3	Edema (Dropsy) 09/2014 - 06/2010
3	Bacterial Infections (Bacterial Infection) 01/2014 - 10/2007
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2012 - 06/2006
3	Metaplasia 09/2007 - 11/2006
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2018
2	Systemic Scleroderma (Systemic Sclerosis) 11/2019 - 06/2012
2	Hemolysis 01/2018 - 01/2011
2	Hyperoxia 08/2017 - 09/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2012
2	Pre-Eclampsia (Preeclampsia) 11/2015 - 02/2015
2	Granuloma 01/2011 - 06/2008
2	Sepsis (Septicemia) 07/2010 - 10/2007
2	Hyperplasia 05/2010 - 06/2007

Drug/Important Bio-Agent (IBA)

65	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 02/2002
32	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2018 - 02/2003
22	Adenosine DeaminaseIBA 01/2016 - 02/2002
20	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 04/2006
11	EnzymesIBA 01/2016 - 01/2005
10	CytokinesIBA 07/2018 - 01/2006
10	Interleukin-6 (Interleukin 6)IBA 02/2016 - 06/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2008
5	Messenger RNA (mRNA)IBA 10/2019 - 06/2008
5	Adenosine A2B ReceptorIBA 08/2016 - 12/2013
5	NucleosidesIBA 02/2016 - 02/2003
5	CollagenIBA 01/2016 - 08/2005
5	ChemokinesIBA 01/2010 - 08/2003
4	Dipyridamole (Persantine)FDA LinkGeneric 01/2021 - 08/2013
4	5'-Nucleotidase (5' Nucleotidase)IBA 01/2018 - 04/2006
4	MucinsIBA 01/2014 - 11/2006
4	OsteopontinIBA 07/2013 - 01/2010
4	AllergensIBA 01/2011 - 11/2006
3	Pharmaceutical PreparationsIBA 01/2019 - 09/2010
3	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 12/2013
3	Interleukin-10 (Interleukin 10)IBA 07/2018 - 10/2007
3	Methacholine Chloride (Methacholine)FDA Link 02/2015 - 06/2007
3	Interleukin-13IBA 09/2014 - 08/2003
3	AntigensIBA 09/2014 - 09/2007
3	Interleukin-4 (Interleukin 4)IBA 09/2014 - 05/2006
3	OvalbuminIBA 09/2014 - 09/2007
3	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2013 - 03/2013
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2010 - 05/2006
2	OccludinIBA 01/2021 - 09/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019 - 01/2019
2	3' Untranslated Regions (3' UTR)IBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2018
2	EndotoxinsIBA 07/2018 - 01/2011
2	InterleukinsIBA 07/2018 - 06/2008
2	MicroRNAs (MicroRNA)IBA 10/2017 - 09/2017
2	Oxygen (Dioxygen)IBA 08/2017 - 09/2014
2	Cell Surface ReceptorsIBA 08/2017 - 02/2010
2	NucleotidesIBA 05/2017 - 04/2016
2	Purinergic Receptors (Receptors, Purine)IBA 05/2017 - 01/2017
2	Inosine FDA Link 01/2017 - 07/2006
2	Equilibrative Nucleoside Transporter 1IBA 01/2017 - 01/2012
2	OzoneIBA 11/2015 - 07/2013
2	Deoxycytidine KinaseIBA 12/2014 - 05/2013
2	Transcription Factors (Transcription Factor)IBA 02/2014 - 11/2011
2	Angiotensin IIIBA 05/2013 - 01/2012
2	3- ethyl- 1- propyl- 8- (1- (3- trifluoromethylbenzyl)- 1H- pyrazol- 4- yl)- 3,7- dihydropurine- 2,6- dioneIBA 06/2012 - 08/2006
2	Adenosine Triphosphate (ATP)IBA 01/2011 - 01/2007
2	TrehaloseIBA 01/2011 - 06/2008
2	GlycolipidsIBA 01/2011 - 06/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 02/2008
2	purineIBA 09/2007 - 01/2005
2	2-Chloroadenosine (2 Chloroadenosine)IBA 01/2007 - 02/2005
1	Nerve Growth Factor (NGF)IBA 12/2020
1	Nicotine FDA Link 12/2020
1	Nerve Growth Factors (Neurotrophins)IBA 12/2020
1	Interferon Type IIBA 11/2019
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 11/2019

Therapy/Procedure

10	Therapeutics 08/2016 - 08/2006
6	Enzyme Therapy 06/2014 - 02/2002
2	Artificial Respiration (Mechanical Ventilation) 01/2018 - 09/2017
2	Enzyme Replacement Therapy 11/2012 - 06/2006